Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India · Delayed Price · Currency is INR 1,773.40
+3.50 (0.20%)
Nov 4, 2026, 3:29 PM IST
NSE:SUNPHARMA Market Cap
NSE:SUNPHARMA has a market cap or net worth of 4.25 trillion as of November 4, 2026. It is the 559th most valuable company in the world and the 16th biggest in India. Its market cap has increased by 3.93% in one year.
Market Cap
4.25T
Enterprise Value
3.95T
Revenue
616.31B
Global Rank
Country Rank
#16 India
PE Ratio
38.80
ChartMarket Cap Chart
Since February 15, 2001, NSE:SUNPHARMA's market cap has increased from 27.61B to 4.25T, an increase of 15,310.63%. That is a compound annual growth rate of 21.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 4.25T | 3.12% |
| Dec 31, 2025 | 4.13T | -8.83% |
| Dec 31, 2024 | 4.53T | 49.78% |
| Dec 29, 2023 | 3.02T | 25.77% |
| Dec 30, 2022 | 2.40T | 18.41% |
| Dec 31, 2021 | 2.03T | 42.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.60T |
| Laurus Labs | 1.30T |
| Zydus Lifesciences | 1.24T |
| Cipla | 1.11T |
| Mankind Pharma | 1.03T |
| Aurobindo Pharma | 967.44B |
| Glenmark Pharmaceuticals | 648.69B |
| Alkem Laboratories | 611.40B |